scispace - formally typeset
H

Hiroyuki Mano

Researcher at University of Tokyo

Publications -  308
Citations -  24554

Hiroyuki Mano is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 66, co-authored 275 publications receiving 22190 citations. Previous affiliations of Hiroyuki Mano include Astellas Pharma & Nagasaki University.

Papers
More filters
Journal ArticleDOI

Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.

TL;DR: TFF‐1 is not only a biomarker, but also a potential molecular target for non‐TRU‐type lung adenocarcinomas with gastrointestinal features, and the knockdown of Tff‐1 inhibited cell proliferation and soft‐agar colony formation and induced apoptosis in a TFF‐ 1‐high and KRAS‐mutated lung adeccarcinoma cell line.
Journal ArticleDOI

Stratification of acute myeloid leukemia based on gene expression profiles.

TL;DR: Global profiling of gene expression in AML blasts has the potential both to identify a small number of genes whose expression is associated with clinical outcome and to provide insight into the molecular pathogenesis of this condition.
Journal ArticleDOI

Presence of a genistein‐responsive inhibitory mechanism on interleukin‐1α‐induced NF‐κB activation

TL;DR: It is found that genistein, a tyrosine kinase inhibitor, augmented IL-1α-dependent NF-κB activation, suggesting the presence of a tyosine kinases mediating a suppression signal on NF- κB, and suggests the possibility that tyrosin kinase negatively regulates NF-σB.
Journal ArticleDOI

Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors.

TL;DR: Gene expression imbalances were measured for tyrosine kinase (TK) genes using Nanostring in 19 samples of inflammatory myofibroblastic tumor (IMT) in cases were immunohistochemically stained with anaplastic lymphoma kinase and pan-tropomyosin-related-kinase (pan-Trk) antibodies.

Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer.

TL;DR: MuSTA as discussed by the authors is a pipeline for multi-sample long-read transcriptome assembly, which enables construction of a transcriptome from long read sequence data using the constructed transcriptome as a reference, using RNA extracted from 22 clinical breast cancer specimens.